Phibro Animal Health Corporation (PAHC) Expected to Post Earnings of $0.40 Per Share

Analysts forecast that Phibro Animal Health Corporation (NASDAQ:PAHC) will announce earnings per share (EPS) of $0.40 for the current quarter, according to Zacks Investment Research. Zero analysts have made estimates for Phibro Animal Health Corporation’s earnings, with the highest EPS estimate coming in at $0.41 and the lowest estimate coming in at $0.40. Phibro Animal Health Corporation posted earnings of $0.39 per share in the same quarter last year, which would suggest a positive year-over-year growth rate of 2.6%. The business is expected to report its next quarterly earnings results on Monday, February 5th.

On average, analysts expect that Phibro Animal Health Corporation will report full-year earnings of $1.57 per share for the current year, with EPS estimates ranging from $1.55 to $1.58. For the next financial year, analysts expect that the business will report earnings of $1.68 per share, with EPS estimates ranging from $1.65 to $1.73. Zacks Investment Research’s EPS calculations are a mean average based on a survey of analysts that that provide coverage for Phibro Animal Health Corporation.

Phibro Animal Health Corporation (NASDAQ:PAHC) last posted its earnings results on Monday, November 6th. The company reported $0.38 EPS for the quarter, topping the Zacks’ consensus estimate of $0.37 by $0.01. The business had revenue of $193.40 million during the quarter, compared to analyst estimates of $189.89 million. Phibro Animal Health Corporation had a return on equity of 42.75% and a net margin of 8.87%. The company’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.36 EPS.

PAHC has been the topic of a number of research reports. Piper Jaffray Companies set a $41.00 price target on Phibro Animal Health Corporation and gave the stock a “buy” rating in a research note on Friday, October 6th. Zacks Investment Research downgraded Phibro Animal Health Corporation from a “buy” rating to a “hold” rating in a research note on Wednesday, November 1st. BidaskClub downgraded Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 23rd. Credit Suisse Group raised their price target on Phibro Animal Health Corporation from $36.00 to $37.00 and gave the stock an “outperform” rating in a research note on Thursday, August 31st. Finally, ValuEngine downgraded Phibro Animal Health Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, November 9th. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company’s stock. Phibro Animal Health Corporation currently has an average rating of “Hold” and an average target price of $38.25.

TRADEMARK VIOLATION NOTICE: “Phibro Animal Health Corporation (PAHC) Expected to Post Earnings of $0.40 Per Share” was originally reported by TrueBlueTribune and is the property of of TrueBlueTribune. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://www.truebluetribune.com/2017/11/14/phibro-animal-health-corporation-pahc-expected-to-post-earnings-of-0-40-per-share.html.

Shares of Phibro Animal Health Corporation (NASDAQ PAHC) opened at $34.45 on Tuesday. The company has a market capitalization of $1,390.33, a price-to-earnings ratio of 22.61, a price-to-earnings-growth ratio of 4.06 and a beta of 1.35. Phibro Animal Health Corporation has a fifty-two week low of $26.10 and a fifty-two week high of $40.25. The company has a quick ratio of 1.85, a current ratio of 3.26 and a debt-to-equity ratio of 1.91.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 27th. Stockholders of record on Wednesday, December 6th will be given a $0.10 dividend. The ex-dividend date of this dividend is Tuesday, December 5th. This represents a $0.40 annualized dividend and a dividend yield of 1.16%. Phibro Animal Health Corporation’s payout ratio is 23.53%.

In other Phibro Animal Health Corporation news, VP Daniel M. Bendheim sold 5,938 shares of the business’s stock in a transaction that occurred on Wednesday, August 16th. The stock was sold at an average price of $40.04, for a total transaction of $237,757.52. Following the sale, the vice president now directly owns 300 shares of the company’s stock, valued at $12,012. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Richard G. Johnson sold 29,807 shares of the business’s stock in a transaction that occurred on Thursday, September 7th. The stock was sold at an average price of $35.66, for a total value of $1,062,917.62. Following the sale, the chief financial officer now directly owns 4,240 shares in the company, valued at $151,198.40. The disclosure for this sale can be found here. Insiders sold 290,705 shares of company stock worth $10,555,178 over the last 90 days. Company insiders own 51.88% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Vanguard Group Inc. increased its stake in Phibro Animal Health Corporation by 3.0% during the second quarter. Vanguard Group Inc. now owns 1,780,880 shares of the company’s stock worth $65,982,000 after acquiring an additional 51,474 shares during the last quarter. FMR LLC increased its stake in Phibro Animal Health Corporation by 31.9% during the second quarter. FMR LLC now owns 584,463 shares of the company’s stock worth $21,654,000 after acquiring an additional 141,274 shares during the last quarter. State Street Corp increased its stake in Phibro Animal Health Corporation by 6.1% during the first quarter. State Street Corp now owns 489,093 shares of the company’s stock worth $13,745,000 after acquiring an additional 28,273 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Phibro Animal Health Corporation by 11.8% during the third quarter. Dimensional Fund Advisors LP now owns 465,297 shares of the company’s stock valued at $17,239,000 after buying an additional 49,296 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its stake in shares of Phibro Animal Health Corporation by 26.7% during the third quarter. Ameriprise Financial Inc. now owns 430,656 shares of the company’s stock valued at $15,958,000 after buying an additional 90,660 shares during the last quarter. 50.36% of the stock is currently owned by institutional investors.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Get a free copy of the Zacks research report on Phibro Animal Health Corporation (PAHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply